Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2009

01.04.2009 | Article

Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain

verfasst von: I. Suárez-García, A. Rodríguez-Blanco, J. L. Vidal-Pérez, M. A. García-Viejo, M. J. Jaras-Hernández, O. López, A. Noguerado-Asensio

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

The setting for this retrospective cohort study was a specialised tuberculosis unit in Madrid, Spain. The objective was to describe the risk factors for multidrug-resistant tuberculosis (MDR-TB). The medical records of all patients admitted to the unit were reviewed retrospectively to identify factors associated with multidrug resistance. Patients with positive culture for M. tuberculosis and with available drug-susceptibility tests were included. The variables assessed were age, gender, country of origin, homelessness, alcohol consumption, intravenous drug use, methadone substitution therapy, contact with a tuberculosis patient, sputum smear, site of disease, previous tuberculosis treatment, HIV infection, history of imprisonment, diabetes mellitus and chronic obstructive pulmonary disease. Thirty patients with MDR-TB and 666 patients with non-MDR-TB were included from the years 1997 to 2006. The only factors associated with MDR-TB in multivariate analysis were previous tuberculosis treatment (OR: 3.44; 95% CI: 1.58–7.50; p = 0.003), age group 45–64 years (OR: 3.24; 95% CI: 1.34–7.81; p = 0.009) and alcohol abuse (OR: 0.12; 95% CI: 0.03 to 0.55; p = 0.003). In our study, patients who had had previous treatment for tuberculosis, who were 45–64 years of age or who had no history of alcohol abuse were more likely to have MDR-TB.
Literatur
1.
Zurück zum Zitat Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ et al (2006) Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194(4):479–485. doi:10.1086/505877 PubMedCrossRef Zignol M, Hosseini MS, Wright A, Weezenbeek CL, Nunn P, Watt CJ et al (2006) Global incidence of multidrug-resistant tuberculosis. J Infect Dis 194(4):479–485. doi:10.​1086/​505877 PubMedCrossRef
2.
Zurück zum Zitat Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A et al (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 344(17):1294–1303. doi:10.1056/NEJM200104263441706 PubMedCrossRef Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A et al (2001) Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 344(17):1294–1303. doi:10.​1056/​NEJM200104263441​706 PubMedCrossRef
3.
Zurück zum Zitat EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region (2007) Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2005. Institut de veille sanitaire, Saint-Maurice EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region (2007) Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2005. Institut de veille sanitaire, Saint-Maurice
4.
Zurück zum Zitat Servicio de Epidemiología (2006) Instituto de Salud Pública. Registro Regional de casos de Tuberculosis de la Comunidad de Madrid. Informe del año 2004. Bol Epidemiol Comun Madr 5(12):4–38 Servicio de Epidemiología (2006) Instituto de Salud Pública. Registro Regional de casos de Tuberculosis de la Comunidad de Madrid. Informe del año 2004. Bol Epidemiol Comun Madr 5(12):4–38
6.
Zurück zum Zitat Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, Rusch-Gerdes S et al (2005) A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist 11(1):62–67. doi:10.1089/mdr.2005.11.62 PubMedCrossRef Casal M, Vaquero M, Rinder H, Tortoli E, Grosset J, Rusch-Gerdes S et al (2005) A case-control study for multidrug-resistant tuberculosis: risk factors in four European countries. Microb Drug Resist 11(1):62–67. doi:10.​1089/​mdr.​2005.​11.​62 PubMedCrossRef
7.
Zurück zum Zitat Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE et al (2001) Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 5(10):887–893PubMed Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE et al (2001) Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis 5(10):887–893PubMed
8.
Zurück zum Zitat Torres L, Arazo P, Blas Perez J, del Pilar Amador M, Antonia Lezcano M, Jose Revillo M et al (2000) Resistance of Mycobacterium tuberculosis in Zaragoza, Spain (1993–1997) and related factors. Med Clin (Barc) 115(16):605–609 Torres L, Arazo P, Blas Perez J, del Pilar Amador M, Antonia Lezcano M, Jose Revillo M et al (2000) Resistance of Mycobacterium tuberculosis in Zaragoza, Spain (1993–1997) and related factors. Med Clin (Barc) 115(16):605–609
9.
Zurück zum Zitat Martin-Casabona N, Alcaide F, Coll P, Gonzalez J, Manterola JM, Salvado M et al (2000) Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis. Med Clin (Barc) 115(13):493–498 Martin-Casabona N, Alcaide F, Coll P, Gonzalez J, Manterola JM, Salvado M et al (2000) Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis. Med Clin (Barc) 115(13):493–498
10.
Zurück zum Zitat Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V et al (2005) Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 9(6):640–645PubMed Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V et al (2005) Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 9(6):640–645PubMed
11.
Zurück zum Zitat World Health Organization (2007) Global tuberculosis control: surveillance, planning and financing. World Health Organization, Geneva World Health Organization (2007) Global tuberculosis control: surveillance, planning and financing. World Health Organization, Geneva
12.
Zurück zum Zitat Canetti G, Rist N, Grosset J (1963) Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev Tuberc Pneumol (Paris) 27:217–272 Canetti G, Rist N, Grosset J (1963) Measurement of sensitivity of the tuberculous bacillus to antibacillary drugs by the method of proportions. Methodology, resistance criteria, results and interpretation. Rev Tuberc Pneumol (Paris) 27:217–272
13.
Zurück zum Zitat Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G (2002) Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis 6(5):406–414PubMed Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G (2002) Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia. Int J Tuberc Lung Dis 6(5):406–414PubMed
14.
Zurück zum Zitat World Health Organization (2006) Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, Geneva World Health Organization (2006) Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization, Geneva
15.
Zurück zum Zitat Spradling P, Nemtsova E, Aptekar T, Shulgina M, Rybka L, Wells C et al (2002) Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Int J Tuberc Lung Dis 6(9):757–762PubMed Spradling P, Nemtsova E, Aptekar T, Shulgina M, Rybka L, Wells C et al (2002) Anti-tuberculosis drug resistance in community and prison patients, Orel Oblast, Russian Federation. Int J Tuberc Lung Dis 6(9):757–762PubMed
16.
Zurück zum Zitat Garcia Rodriguez JF, Marino Callejo A, Lorenzo Garcia MV, Rodriguez Mayo M, Dominguez Gomez D, Sesma Sanchez P (1999) Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors. Med Clin (Barc) 113(15):572–574 Garcia Rodriguez JF, Marino Callejo A, Lorenzo Garcia MV, Rodriguez Mayo M, Dominguez Gomez D, Sesma Sanchez P (1999) Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors. Med Clin (Barc) 113(15):572–574
18.
Zurück zum Zitat Fleming MF, Krupitsky E, Tsoy M, Zvartau E, Brazhenko N, Jakubowiak W et al (2006) Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis 10(5):565–570PubMed Fleming MF, Krupitsky E, Tsoy M, Zvartau E, Brazhenko N, Jakubowiak W et al (2006) Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int J Tuberc Lung Dis 10(5):565–570PubMed
19.
Zurück zum Zitat Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S et al (2006) Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 10(4):402–408PubMed Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S et al (2006) Treatment outcomes in an integrated civilian and prison MDR-TB treatment program in Russia. Int J Tuberc Lung Dis 10(4):402–408PubMed
20.
Zurück zum Zitat Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Kourbatova EV (2007) Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis 11(1):46–53PubMed Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Kourbatova EV (2007) Risk factors associated with default among new pulmonary TB patients and social support in six Russian regions. Int J Tuberc Lung Dis 11(1):46–53PubMed
21.
Zurück zum Zitat Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG et al (2002) Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 6(9):780–788PubMed Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG et al (2002) Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 6(9):780–788PubMed
22.
Zurück zum Zitat Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T et al (2007) Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India. Indian J Tuberc 54(3):130–135PubMed Jaggarajamma K, Sudha G, Chandrasekaran V, Nirupa C, Thomas A, Santha T et al (2007) Reasons for non-compliance among patients treated under Revised National Tuberculosis Control Programme (RNTCP), Tiruvallur district, south India. Indian J Tuberc 54(3):130–135PubMed
23.
Zurück zum Zitat Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV et al (2007) Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 85(9):703–711. doi:10.2471/BLT.06.038331 PubMedCrossRef Gelmanova IY, Keshavjee S, Golubchikova VT, Berezina VI, Strelis AK, Yanova GV et al (2007) Barriers to successful tuberculosis treatment in Tomsk, Russian Federation: non-adherence, default and the acquisition of multidrug resistance. Bull World Health Organ 85(9):703–711. doi:10.​2471/​BLT.​06.​038331 PubMedCrossRef
24.
Zurück zum Zitat Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM (2006) A population-based study of risk factors for drug-resistant TB in British Columbia. Int J Tuberc Lung Dis 10(6):631–638PubMed Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM (2006) A population-based study of risk factors for drug-resistant TB in British Columbia. Int J Tuberc Lung Dis 10(6):631–638PubMed
25.
Zurück zum Zitat Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A et al (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196 [Suppl 1]:S86–S107. doi:10.1086/518665 PubMedCrossRef Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A et al (2007) HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 196 [Suppl 1]:S86–S107. doi:10.​1086/​518665 PubMedCrossRef
26.
Zurück zum Zitat De March Ayuela P (2001) Drug-resistant tuberculosis in Spain. Trends and influence of the human immunodeficiency virus. Med Clin (Barc) 117(2):59–63 De March Ayuela P (2001) Drug-resistant tuberculosis in Spain. Trends and influence of the human immunodeficiency virus. Med Clin (Barc) 117(2):59–63
27.
Zurück zum Zitat Grupo de Estudio de Tuberculosis Resistente de Madrid Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993–April 1994) (1996) Med Clin (Barc) 106(1):1–6 Grupo de Estudio de Tuberculosis Resistente de Madrid Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993–April 1994) (1996) Med Clin (Barc) 106(1):1–6
29.
Zurück zum Zitat Drobniewski FA, Watterson SA, Wilson SM, Harris GS (2000) A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol 49(3):271–278PubMed Drobniewski FA, Watterson SA, Wilson SM, Harris GS (2000) A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. J Med Microbiol 49(3):271–278PubMed
Metadaten
Titel
Risk factors for multidrug-resistant tuberculosis in a tuberculosis unit in Madrid, Spain
verfasst von
I. Suárez-García
A. Rodríguez-Blanco
J. L. Vidal-Pérez
M. A. García-Viejo
M. J. Jaras-Hernández
O. López
A. Noguerado-Asensio
Publikationsdatum
01.04.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2009
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0627-y

Weitere Artikel der Ausgabe 4/2009

European Journal of Clinical Microbiology & Infectious Diseases 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.